FDA Approves First Myopia-Control Spectacle Lens for Children
According to this report, the FDA has approved the Essilor Stellest lens, the first spectacle lens in the US
designed to slow myopia progression in children. Already used internationally, Stellest lenses use over 1,000 tiny lenslets arranged in concentric rings to create peripheral defocus, interrupting signals that drive eye elongation. A two-year clinical trial showed a 71% reduction in myopia progression and a 53% decrease in axial length growth compared with standard single-vision lenses, with no serious adverse effects. The lens is indicated for children aged 6–12 and must be worn at least 12 hours daily. Availability in the US is expected within weeks.
Comments
Post a Comment
Leave a Comment or Question: